← Leaderboards
Robert Yeh
Beth Israel Deaconess Medical Center
$7,955,025
Attributed
$11,521,631
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,521,631 · 5
By mechanism
R01$10,049,659 · 3
K23$740,232 · 1
K24$731,740 · 1
Top collaborators
- Robert E Gerszten4 shared
- Dhruv Satish Kazi4 shared
- Issa J. Dahabreh3 shared
- Navin Kumar Kapur1 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Robert E Gerszten$34,860,502
- Dhruv Satish Kazi$2,785,213
- Eric A Osborn$657,504
- Catherine Bielick$382,968
Others in their field
Top investigators on “Cardiovascular System”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Judith S Hochman · New York University School Of Medicine$110,228,771
Research focus
Cardiovascular SystemRegistriesMedicalClinical TrialsTreatment EffectMorbidity - Disease RateHealth SystemLinkCommunitiesPatient CareMortalityCoronaryInsightHigh RiskData RegistryHospitalsEvaluationData SetStentsTreatment StrategyCaringCharacteristicsPublic HealthCardiovascular Diseases
Grant awards (24)
Application of Modern Methods to Predict Risk and Estimate Treatment Effectiveness in Cardiogenic Shock$817,358
R01 · FY2025 · HL · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Devices$737,416
R01 · FY2025 · HL · contact PI
Mentoring and Research in Cardiovascular Device Evaluation$130,270
K24 · FY2025 · HL · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Devices$735,551
R01 · FY2024 · HL · contact PI
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events$439,554
R01 · FY2024 · HL · contact PI
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease$120,294
K24 · FY2024 · HL · contact PI
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events$865,807
R01 · FY2023 · HL · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Devices$776,920
R01 · FY2023 · HL · contact PI
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease$120,294
K24 · FY2023 · HL · contact PI
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events$870,905
R01 · FY2022 · HL · contact PI
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease$120,294
K24 · FY2022 · HL · contact PI
A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events$873,210
R01 · FY2021 · HL · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Therapies in Clinical Trials$771,542
R01 · FY2021 · HL · contact PI
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease$120,294
K24 · FY2021 · HL · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Therapies in Clinical Trials$791,049
R01 · FY2020 · HL · contact PI
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease$120,294
K24 · FY2020 · HL · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Therapies in Clinical Trials$749,641
R01 · FY2019 · HL · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Therapies in Clinical Trials$756,588
R01 · FY2018 · HL · contact PI
Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Therapies in Clinical Trials$864,118
R01 · FY2017 · HL · contact PI
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio$164,376
K23 · FY2017 · HL · contact PI
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio$164,376
K23 · FY2016 · HL · contact PI
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio$137,160
K23 · FY2015 · HL · contact PI
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio$137,160
K23 · FY2014 · HL · contact PI
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio$137,160
K23 · FY2013 · HL · contact PI